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PreviewsLife is fragile. Within multicellular 
organisms, cells are bombarded with 
signals from within and from without 
in a constant struggle between life 
and death. When the balance tips 
toward death, cells undergo a ste-
reotypical series of morphological 
changes in the process known as 
apoptosis. They shrink, break con-
tacts with neighboring cells, bleb; 
their microvilli disappear, their nuclei 
condense, and their chromosomes 
fragment. Cells undergo apoptosis 
for a variety of reasons, sometimes 
to the benefit of the organ-
ism, sometimes to its detri-
ment. So, understanding the 
mechanisms that regulate 
the balance between life and 
death is of obvious impor-
tance. In addition, many 
components of the apoptosis 
molecular machinery partici-
pate in cellular activities that 
are non-life-threatening (Fig-
ure 1). Work described in two 
new papers (Kuranaga et al., 
2006; Oshima et al., 2006) 
now identifies a new kinase 
that regulates actin dynam-
ics, cell morphology, and cell 
differentiation via the non-
apoptotic functions of the cell 
death pathway.
In this issue of Cell, 
Kuranaga et al. (2006) dem-
onstrate that DmIKKε is a 
new type of antagonist of the 
DIAP1 (Drosophila inhibitor 
of apoptosis 1) protein. Inde-
pendently of other known 
antagonists, DmIKKε phos-
phorylates DIAP1, leading to its 
degradation (Figure 1). The authors 
first carried out a genetic screen in 
the fruit fly Drosophila for mutations 
that modify the eye-loss phenotype 
caused by overexpression of the 
proapoptotic gene reaper, which is 
a known antagonist of DIAP1. This 
led them to a previously uncharac-
terized gene that encodes a protein 
kinase, which they named DmIKKε. 
Overexpression of DmIKKε led to 
increased caspase activity and 
apoptotic cell death in imaginal 
discs. Furthermore, they found that 
DIAP1 protein levels were reduced in 
cells overexpressing DmIKKε, both 
in vivo and in vitro. In cultured S2 
cells, DmIKKε associated with and 
phosphorylated DIAP1. In addition, 
expression of NAK (NF-κB-activat-
ing kinase)—the human ortholog of 
DmIKKε—in S2 cells caused deple-
tion of DIAP1 and cell death. NAK 
also phosphorylated XIAP, one of 
the mammalian IAPs, suggesting 
that this relationship has been con-
served during evolution.
These observations are 
important because they iden-
tify DmIKKε as a new deter-
minant of IAP protein level, 
which can mean the differ-
ence between life and death. 
IAPs bind to caspases and 
inhibit their activities, and 
caspases are primary molec-
ular arbiters of apoptosis. 
Proteins such as Reaper bind 
to DIAP1 and cause it to self-
destruct, thereby derepress-
ing caspase activity and pro-
moting apoptosis (Figure 1). 
If the level of DIAP1 exceeds 
that of its antagonists, cas-
pases will be shut down and 
the cell will live; otherwise, it 
will die.
But that is not the whole 
story because DIAP1 and 
caspases do not exist solely 
to inhibit cell death. DIAP1 
can also promote cell migra-
tion, and caspases have been 
shown to control a variety 
of nonapoptotic functions 
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Two new papers (Kuranaga et al., 2006; Oshima et al., 2006) describe a previously unchar-
acterized Drosophila kinase (DmIKKε) that regulates the abundance of DIAP1, a protein 
best known for its ability to inhibit apoptosis. However, DmIKKε-mediated degradation 
of DIAP1 does not regulate apoptosis as might be predicted but instead regulates actin 
dynamics, cell morphology, and the differentiation of sensory organ precursor cells.
Figure 1. The Regulation and Functions of Caspases
The fly protein DIAP1 is a direct inhibitor of both the apical 
caspase DRONC and the effector caspases that DRONC ac-
tivates. A frequent consequence of such caspase activation is 
apoptosis. However, both apical and effector caspases have 
been implicated in nonapoptotic functions, such as the differ-
entiation of sensory organ precursors (Kuranaga et al., 2006), 
sperm individualization (Arama et al., 2003), border cell migra-
tion (Geisbrecht and Montell, 2004), and the morphology of 
sensory and tracheal cells (Oshima et al., 2006).450 Cell 126, August 11, 2006 ©2006 Elsevier Inc.
including cell proliferation, differen-
tiation, morphogenesis, and migra-
tion. Nonapoptotic functions have 
been discovered in both mammals 
(Launay et al., 2005; Schwerk and 
Schulze-Osthoff, 2003) and Dro-
sophila (Cashio et al., 2005) .
The new work by Kuranaga et 
al. (2006) combines in vivo genetic 
experiments with biochemical anal-
ysis of proteins expressed in cul-
tured cells to define the function 
of DmIKKε. Although high levels of 
DmIKKε expression in vivo cause 
apoptosis, and although reducing 
DmIKKε inhibited artificially induced 
cell death, the normal function of 
this kinase does not appear to be 
regulation of apoptosis. Reduction of 
DmIKKε expression does not lead to 
increased apoptosis in embryos or 
imaginal discs, even though it does 
reduce caspase activity. So what is 
the function of DmIKKε-mediated 
caspase activation, if not to control 
apoptosis? In earlier work, the same 
lab showed that caspase activity can 
be detected in imaginal disc cells that 
are not undergoing apoptosis and 
that sensory organ precursor (SOP) 
development depends on caspase 
activity but not apoptosis (Kanuka et 
al., 2005). They also showed that the 
apical caspase DRONC can cleave 
and thereby activate one particular 
isoform of the kinase Shaggy, which 
participates in Wingless signaling. 
The new work shows that the num-
ber of SOP cells is also affected 
by DmIKKε through this previously 
defined nonapoptotic function of 
DRONC.
In a collaborative and comple-
mentary study recently published in 
Current Biology, Oshima et al. (2006) 
came across the same DmIKKε gene 
in a different genetic screen. These 
investigators screened for genes that, 
when overexpressed, caused defects 
in the organization of the Drosophila 
tracheal system, an interconnected 
network of tubes that constitutes the 
breathing system of the fly. Oshima 
et al. found that overexpression of 
DmIKKε caused loss of apical-basal 
polarity in tracheal epithelial cells and, 
as a consequence, disorganization 
of the tracheal network. Suspecting that the actin cytoskeleton might be 
involved, they directly examined the 
effects of inhibiting or enhancing the 
activity of DMIKKε on actin dynamics 
in cultured S2 cells. Expression of a 
dominant-negative kinase caused 
morphological changes in the cells 
and enhanced the stability of the 
actin cytoskeleton. Shrinkage of the 
dynamic domain of peripheral actin 
was also observed in ruffling cells, 
and, together, these observations 
suggested that DmIKKε might be a 
negative regulator of F-actin polym-
erization. Consistent with this notion, 
overexpression of the kinase desta-
bilized the actin cytoskeleton and 
caused excess membrane ruffling. 
These effects were apparently inde-
pendent of apoptosis. The investiga-
tors went on to examine the effect 
of manipulating DmIKKε function in 
specific cells in vivo, either reducing 
or increasing its activity. They found 
a variety of effects on the morphol-
ogy of actin-based structures such 
as sensory bristles, tracheal cell pro-
trusions, and lateral branches of the 
arista (thin sensory protrusions that 
extend off of the fly antenna). For 
example, DmIKKε depletion caused 
ectopic branching of each of these 
structures, a phenotype that is also 
observed following overexpression 
of well-characterized regulators of 
actin polymerization such as pro-
filin. Based on genetic interactions, 
ectopic branching observed follow-
ing depletion of DmIKKε appears to 
result from excess DIAP1 protein.
So how does excess DIAP1 lead 
to increased branching of actin-
rich protrusions? A previous study 
showed that DIAP1 overexpres-
sion suppressed defects in border 
cell migration that were caused by 
dominant-negative Rac, another 
well-characterized regulator of cell 
morphology and actin protrusions. 
Dominant-negative DRONC also 
rescued the phenotype (Geisbrecht 
and Montell, 2004). Consistent with 
these observations, Oshima et al. 
(2006) found that overexpression of 
DIAP1 or dominant-negative DRONC 
enhanced the excessive branching 
caused by low DmIKKε.
Taken together, the new data Cell 126, in both papers show that DmIKKε 
functions as a negative regulator of 
DIAP1 protein levels and is thereby a 
positive regulator of caspase activity. 
The primary function of DmIKKε in 
vivo seems to be to promote the non-
apoptotic functions of the caspase 
DRONC in a variety of cell types. 
These functions include specification 
of SOPs on the one hand and regu-
lation of actin polymerization and 
actin-based cell morphology on the 
other. This intriguing new work adds 
to the existing literature implicat-
ing caspases and their regulators in 
nonapoptotic functions and raises a 
number of compelling questions. For 
example, what activates DmIKKε? 
One study in cultured HEK293 cells 
showed that the platelet-derived 
growth factor (PDGF) stimulates NAK 
activity via protein kinase C, provid-
ing one possible mechanism of acti-
vation of the mammalian homolog of 
DmIKKε (Tojima et al., 2000). How-
ever, it is unclear whether this is the 
only activation pathway or whether 
there might be different inputs in dif-
ferent biological contexts. In keeping 
with this idea, NAK was originally 
identified as regulating the NF-κB 
pathway, which is not related in any 
obvious way to the new findings.
A second question concerns 
the identity of the critical targets of 
DRONC in its nonapoptotic functions. 
With respect to changes in cell mor-
phology and actin organization, the 
small GTPase Rac, actin, and other 
proteins that affect actin are known 
caspase targets. Which of these, if 
any, mediate the reported biological 
effects remains to be determined.
What is the unifying theme, if any, 
between the different biological pro-
cesses that employ caspase activity? 
Some of the differentiation events 
controlled by caspases, such as 
lens differentiation and sperm indi-
vidualization, resemble incomplete 
apoptosis. For example, the nucleus 
is extruded from differentiated lens 
cells, whereas in sperm individual-
ization, the cytoplasmic volume is 
reduced while the nucleus is spared. 
In these cases, it is not difficult to 
imagine how the apoptotic machinery 
came to be involved. But what about August 11, 2006 ©2006 Elsevier Inc. 451
the others? Apoptosis was originally 
described as a series of morphologi-
cal changes. One possibility is that a 
subset of the morphological changes 
associated with apoptosis are related 
to normal changes that cells undergo 
during development. For example, 
apoptotic cells round up, detach 
from their neighbors, and undergo 
reorganization of the actin cytoskel-
eton, behaviors that also character-
ize motile cells leaving an epithelium. 
Perhaps certain cells have harnessed 
the activities of caspases and their 
regulators in order to accomplish a 
subset of the features of apoptosis 
and put them to use. But how do they 
survive in the presence of activated 
caspase? Is caspase activity physi-
cally compartmentalized so that 452 Cell 126, August 11, 2006 ©2006 Elsaccess to substrates is very limited? 
Or is it simply a question of the level 
of caspase activity that determines 
how a cell responds? Perhaps the 
presence (or absence) of other fac-
tors limits the effects of an active 
caspase? Might the answers be dif-
ferent for different cell types? These 
are some of the questions that prom-
ise to keep investigators interested in 
life and death busy for the foresee-
able future.
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